Clinical studies have demonstrated that tissue plasminogen activator (tPA) effectively dissolves thrombi, restoring cerebral perfusion and rescuing neurons when administered within 4.5 h of stroke onset (Moran and Rubin, 2022; Havenon et al., 2023). The gene discussed is PLAT; the disease is Stroke.